MINNEAPOLIS, Minnesota—DynaPulse Medical LLC, a provider of medical devices for circulatory and neuromuscular health, announced its acquisition of Veinoplus, a provider of electro-stimulation therapy solutions. This move strengthens DynaPulse Medical LLC’s mission to elevate patient care and expand its portfolio of cutting-edge health care technologies.
By combining Veinoplus’s electro-stimulation devices with its Second Heart technology, the company said it will be poised to deliver enhanced solutions for chronic venous insufficiency (CVI), peripheral arterial disease (PAD), deep vein thrombosis (DVT) prevention and other related conditions.
“This acquisition marks a transformative step for DynaPulse Medical LLC, perfectly aligning with our vision of offering clinically proven, non-invasive treatments,” said Steffen Magnell, CEO of DynaPulse Medical LLC. “Veinoplus’s advanced technology amplifies our ability to improve patient outcomes and quality of life.”
Through this acquisition, DynaPulse Medical LLC will launch an expanded line of products designed to boost circulation, reduce pain and support those managing circulatory and neuromuscular challenges.
Key Benefits of the Acquisition:
- Broader Market Reach: Strengthened position in the medical devices market for circulatory and neuromuscular conditions, catering to a wider range of patient needs.
- Increased Clinical Efficacy: Enhanced focus on clinically supported electro-stimulation solutions, backed by documented case studies and trusted by leading medical practitioners.
- User-Friendly Solutions: An easy-to-use, home-based device that ensures patients can receive effective treatment with minimal inconvenience.